Table 2.
Type and number of organs resected during MVR.
| Authors | Organs Resected n, % (95% CI) |
||||||
|---|---|---|---|---|---|---|---|
| SP | C | L | P | SB | GB | O | |
| Amin et al. [5] | 12, 42.86% (26.49–60.95%) |
11, 39.29% (23.52–57.63%) |
3, 10.71% (2.9–28.01%) |
2, 7.14% (0.9–23.73%) |
- | - | - |
| Carboni et al. [4] | 34, 33.01% (24.66–42.58%) |
16, 15.53%, (9.69–23.86%) | 12, 11.65% (6.65–19.41%) |
28, 27.18% (19.49–36.52%) |
1, 0.97% (0.01–5.83%) |
2, 1.94% (0.1–7.23%) |
10, 9.71% (5.19–17.13%) |
| Cheng et al. [15] | 46, 24.08% (18.55–30.64%) |
24, 12.57%, (8.53–18.07%) | 16, 8.38% (5.14–13.26%) |
54, 28.27%, (22.35–35.05%) | 12, 6.28% (3.53–10.76%) |
13, 6.81% (3.92–11.39%) |
6, 3.14% (1.29–6.84%) |
| Colen et al. [25] | 13, 37.14% (23.12–53.71%) |
5, 14.29% (5.78–29.85%) |
2, 5.71% (0.62–19.57%) |
12, 34.29% (20.76–50.92%) |
3, 8.57% (2.21–23.13%) |
- | - |
| Dias et al. [26] | 32, 26.89% (19.71–35.52%) |
29, 24.37% (17.5–32.85%) |
14, 11.76% (7.02–18.9%) |
44, 36.97% (28.83–45.94%) |
- | - | |
| Isozaki et al. [16] | 31, 41.33% (30.87–52.64%) |
- | - | 31, 41.33% (30.87–52.64%) |
- | - | 13, 17.33% (10.28–27.57%) |
| Jeong et al. [17] | 29, 35.37% (25.87–46.18%) |
9, 10.98% (5.67–19.77%) |
4, 4.88% (1.54–12.26%) |
37, 45.12% (34.81–55.87%) |
- | - | 5, 6.1% (2.3–13.82%) |
| Kim et al. [18] | 13, 33.33% (20.56–49.09%) |
15, 38.46% (24.86–54.13%) |
- | 10, 25.64% (14.41–41.24%) |
- | 1, 2.56% (0.01–14.36%) |
- |
| Kobayasbi et al. [27] | - | 35, 36.46% (27.51–46.45%) |
10, 10.42% (5.58–18.3%) |
36, 37.5% (28.46–47.5%) |
- | - | 15, 15.63% (9.59–24.31%) |
| Martin et al. [28] | 251, 52.4% (47.93–56.84%) |
36, 7.52% (5.45–10.25%) |
65, 13.57% (10.78–16.94%) |
33, 6.89% (4.92–9.54%) |
27, 5.64% (3.87–8.11%) |
27, 5.64% (3.87–8.11%) |
40, 8.35% (6.17–11.19%) |
| Min et al. [19] | - | 169, 65.76% (59.76%, -71.29%) |
67, 26.07% (21.07–31.77%) |
21, 8.17% (5.35–12.22%) |
- | - | - |
| Mita et al. [22] | 30, 27.03% (19.60–35.99%) |
14, 12.61% (7.54–20.18%) |
48, 43.24% (43.40–52.54%) |
12, 10.81% (6.15–18.09%) |
- | 2, 1.80% (0.09–6.74%) |
7, 6.31% (2.87–12.66%) |
| Pacelli et al. [8] | 8, 5.16% (2.48–10.01%) |
43, 27.74% (21.28–35.28%) |
46, 29.68% (23.03–37.31%) |
17, 10.97% (6.87–16.95%) |
- | - | 41, 26.45% (20.12–33.93%) |
| Molina et al. [9] | 12, 23.53% (13.87–36.9%) |
6, 11.76% (5.14–23.75%) |
17, 33.33% (21.92–47.08%) |
10, 19.61% (10.82–32.65%) |
- | - | 6, 11.76% (5.14–23.75%) |
| Shchepotin et al. [29] | 150, 25.13% (21.81–28.76%) |
159 (26.63%, 23.24–30.32%) |
187 (31.32%, 27.73–35.16%) |
101 (16.92%, 14.12–20.14%) |
- | - | - |
| Wang et al. [20] | - | 22 | - | - | - | - | |
| Yang et al. [21] | 86, 33.46% (27.97–39.44%) |
43, 16.73% (12.64–21.80%) |
81, 31.52% (26.14–37.44%) |
15, 5.84% (3.50–9.48%) |
- | - | 32, 12.45% (8.92–17.09%) |
| Mita et al. [30] | 54, 48.21% (39.17–57.37%) |
10, 8.93% (4.76–15.82%) |
33, 29.46% (21.79–38.50%) |
4, 3.57% (1.10–9.12%) |
1, 0.89% (0.01–5.38%) |
1, 0.89% (0.01–5.38%) |
9, 8.04% (4.11–14.75%) |
| Xiao et al. [10] | 27, 28.13% (20.07–37.86%) |
23, 23.96% (16.47–33.45%) |
30, 31.25% (22.82–41.12%) |
16, 16.67% (10.42–25.48%) |
- | - | - |
| Ozer et al. [12] | - | 18, 28.13% (18.53–40.20%) |
32, 50.00% (38.10–61.90%) |
8, 12.50% (6.22–23.03%) |
- | 1, 1.56% (0.01–13.45%) |
5, 7.81% (3.00–17.40%) |
| Sahakyan et al. [11] | 34, 26.77% (19.81–35.10%) |
23, 18.11% (12.32–25.77%) |
30, 23.62% (17.04–31.76%) |
16, 12.60% (7.81–19.59%) |
8, 6.30% (3.05–12.12%) |
- | 16, 12.60% (7.81–19.59%) |
| Tran et al. [31] | 76, 48.41% (40.72–56.17%) |
19 (12.10%, 7.81–18.21%) |
42 (26.75%, 20.42–34.19%) |
20 (12.74%, 8.33–18.93%) |
- | - | - |
| Total: | 938, 28.98% (27.44–30.56%) |
729, 22.52% (21.11–23.99%) |
739, 22.83% (21.42–24.31%) |
527, 16.28% (15.05–17.59%) |
52, 1.61% (1.22–2.10%) |
47, 1.45% (1.09–1.93%) |
205, 6.33% (5.54–7.23%) |